Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants
Clinical trial NCT04491838 · COMPLETED
Trial details
- NCT number
- NCT04491838
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2021-03-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.